HK Stock Market Move | DIAGENS-B (02526) Surges Over 13% in Early Trading; Company Positions Itself in the World Model Track, with Imaging-Side Prototype Already Landed

DIAGENS-B (02526) surged over 13% in early trading. As of press time, it was up 6.12% at HK$232.2, with a turnover of HK$26.7043 million. On the news front, recently, Stanford University postdoctoral fellow Ying Kejun, together with scholars from the University of Washington, Harvard Medical School, MIT, and other institutions, published HealthFlux, the first panoramic-modal human health world model, on the medical preprint platform medRxiv. It is widely regarded by the industry as a landmark signal of the next "AlphaFold moment" in the medical AI field. According to "HealthFlux Ignites the Medical World Model Wave: DIAGENS-B (02526) Imaging-Side Prototype Already in Place," Diagens' self-developed iMedLoop platform has gathered more than 300 professional annotators and 28.95 million imaging data records, integrating data, tools, models, and applications to form a cycle of "data productionmodel trainingclinical applicationfeedback iteration": feedback generated during clinical use returns to the model, driving the next round of iteration. The imaging understanding, risk prediction, and multi-specialty R&D capabilities that Diagens has already demonstrated are forming a key piece of the prototype of a medical world model.